This trial was designed to determine the most appropriate dosing strategy for the Phase III program in kidney transplantation. The primary efficacy objective of this trial was to
The patent further extends Lipid Sciences’s ownership over therapeutic HDL compositions provided by the company’s proprietary extracorporeal delipidation process. The company plans to capitalize on this strong IP
This randomized, double-blind, multicenter study included 43 women with breast cancer and metastatic bone disease who received oral odanacatib 5mg daily or intravenous zoledronic acid 4mg on day
The patent specifically claims the Form A polymorph of OPT-80, as well as all dosage forms and pharmaceutical compositions including the Form A polymorph of OPT-80. OPT-80 is
Hospitals included in the agreement are Broward General Medical Center, including the Chris Evert Children’s Hospital, North Broward Medical Center, Imperial Point Medical Center and the Coral Springs
King and Acura entered into a license, development and commercialization agreement in October 2007. The agreement provides King with an exclusive license to Acurox tablets and another undisclosed
Virusmax has enormous implications for protecting more of the world’s population during a pandemic. The entire annual global flu vaccine production capacity is currently only about 350 million
The prospective, randomized, controlled study of 85 patients compared plasma disc decompression (PDD) to conservative care for the treatment of contained cervical disc herniation. The study found that
The financing has been provided by Mesa Verde Venture Partners and other investors in Tucson, San Diego, Phoenix and Washington DC. Mark McWilliams, CEO of Medipacs, said: “We
Medtronic sued Boston Scientific in 2006 asserting that Boston’s Taxus Express2, Express2, Liberte, Maverick, Maverick2, and Quantum Maverick products infringed the Fitzmaurice and Anderson catheter patents owned by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.